OSRH
OSR Health, Inc.
$0.31
-0.01 (-3.38%)
At close · Jul 7
Market Cap
$11.02M
Shares
35,104,995
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.31
Open$0.32
Day$0.31–0.33
52W$0.30–1.49
Avg vol 30d847K
Short int1.4M · 4.1% float · 1.4d
Short vol37%
DataMar 2023–Jul 2026
Filing10-Q · May 13
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−43%
below
Price vs 50-day avg
−34%
below
RSI (14)
32
neutral
MACD trend
Positive
52-week position
1%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−19%
trailing
6-month return
−56%
trailing
YTD return
−44%
this year
Relative strength
−64%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
4.06% of float · ▲ +20.4% MoM · 1.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
11 holders — near 1-yr high, broad support
Squeeze score
54
elevated · 0–100
Fundamentals
Revenue growth
−18%
Y/Y
Gross margin
20%
contracting
EPS growth
+83%
Y/Y
Balance sheet
$315.4K
net debt
Quant / Vol
risk profile
Volatility
148%
annualized · 1-yr
Max drawdown
−77%
past year
ATR
10.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 13, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−43%
Bearish
Price vs 50-day avg
−34%
Bearish
RSI (14)
32
Neutral
MACD trend
Positive
Bullish
52-week position
1%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
4.06% of float · ▲ +20.4% MoM · 1.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
11 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $0
Now $0 · 1%
52-wk high $1
vs 200-day avg -43%
vs 50-day avg -34%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OSRH
this stock
OSR Health, Inc.
|
$11.02M | -44.3% | -17.7% | — | 4.1% |
|
ONC
BeOne Medicines Ltd.
|
$446.53B | +1.7% | +22179.2% | 908.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.50B | +9.9% | +46.2% | 31.0 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.90B | -12.3% | +20.8% | 16.5 | 3.2% |
|
ARGX
Argenx SE
|
$57.20B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OSRH | -2.2% | -19.1% | -56.2% | -0.6% | -44.3% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | -3.1% | -20.5% | -63.8% | -0.8% | -54.0% |